Intellia Therapeutics, Inc. NTLA has put up a dismal performance in 2024. Shares of the company have plunged 60.4% compared with the industry’s decline of 13.7%. The deterioration was more pronounced ...
Source LinkIntellia Therapeutics, Inc. NTLA has put up a dismal performance in 2024. Shares of the company have plunged 60.4% compared with the industry’s decline of 13.7%. The deterioration was more pronounced ...
Source Link
Comments